Quantcast

Golden State Today

Monday, December 23, 2024

FDA conducted second lowest number of inspections on Drugs companies in California during Q1

Webp wpqolpnrcij8e8mt9jfg90exrory

Mark Raza Principal Deputy Chief Counsel - FDA | Official Website

Mark Raza Principal Deputy Chief Counsel - FDA | Official Website

In the first quarter of 2024, six Drugs companies received seven FDA inspections in California, according to the U.S. Food and Drug Administration (FDA).

This was the second lowest number of inspections per type of company made by the FDA in California, equalling 3.4% of all inspections in the first quarter of 2024.

Of all the California companies involved in the Drugs sector, BioDuro, LLC received the most citations from the FDA in the first quarter of 2024.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

Top 10 FDA Inspections by Number of Actions Indicated in California During Q1
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Bioresearch Monitoring--2--
Blood and Blood Products131--
Compliance: Devices97--
Drug Quality Assurance14--
Food Composition, Standards, Labeling and Econ2110--
Foodborne Biological Hazards10436--
Human Cellular, Tissue, and Gene Therapies5----
Monitoring of Marketed Animal Drugs, Feed, and Devices162--
Postmarket Assurance: Devices82--
Technical Assistance: Food and Cosmetics6----

MORE NEWS